Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$5.46
-1.36%
Mkt Cap $1.60B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+156.6%
Consensus $14.00 vs current $5.46
NASDAQ·Healthcare·Biotechnology
$5.46
-1.36%
Mkt Cap $1.60B
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
+156.6%
Consensus $14.00 vs current $5.46